CDKN2A and COVID-19: Bulk and single-cell transcriptomic analyses further support the concept that SARS-CoV-2 triggered senescence drives pathology in COVID-19 and the lungs of patients with severe COVID-19 showed higher levels of p16INK4a positive cells compared with that in individuals with other lung diseases (Schmitt et al., 2022).